Partnerships Partnering News

04.26.2022

Valneva and Pfizer Report Positive Phase 2 Pediatric Data for Lyme Disease Vaccine Candidate

02.14.2022

Pfizer joins the Open Targets consortium

01.31.2022

Pfizer and Ionis Announce Discontinuation of Vupanorsen Clinical Development Program

01.18.2022

Sema4 to Acquire GeneDx, Strengthening its Market-Leading AI-Driven Genomic and Clinical Data Platform

01.11.2022

Dren Bio Announces Research Collaboration and License Agreement with Pfizer to Discover and Advance Multiple Therapeutic Antibodies Using its Targeted Myeloid Engager and Phagocytosis Platform for the Treatment of Cancer

12.16.2021

Anaveon to raise CHF 110 million in oversubscribed Series B financing

11.29.2021

Ranok Therapeutics Announces Agreement with Pfizer on Targeted Protein Degradation

11.18.2021

Cardiff Oncology Announces $15 Million Equity Investment from Pfizer through its Pfizer Breakthrough Growth Initiative

10.13.2021

AION Labs, Biotech Innovation Lab Launched by Top Pharma, Tech and Investment Leaders

09.16.2021

Anjarium Biosciences Raises CHF 55.5M ($61M) Series A Financing to Develop Next-Generation Non-viral Gene Therapies

07.22.2021

Arvinas And Pfizer Announce Global Collaboration To Develop And Commercialize Protac® Protein Degrader Arv-471

07.08.2021

Collaboration Between Abbvie, Biogen And Pfizer Creates World's Largest Browsable Resource Linking Rare Protein-Coding Genetic Variants To Human Health And Disease.